α-
Synuclein is causative for autosomal dominant familial
Parkinson disease and
dementia with Lewy bodies, and the phosphorylation of α-
synuclein at residue Ser-129 is a key posttranslational modification detected in
Parkinson disease/
dementia with Lewy bodies lesions. However, the role of Ser-129 phosphorylation on the pathogenesis of
Parkinson disease/
dementia with Lewy bodies remains unclear. Here we investigated the neurotoxicity of Ser-129-substituted α-
synuclein in the transgenic Caenorhabditis elegans (Tg worm) model of
synucleinopathy. Tg worms pan-neuronally overexpressing nonphosphorylatable (S129A) α-
synuclein showed severe defects including motor dysfunction, growth retardation, and synaptic abnormalities. In contrast, Tg worms expressing phosphorylation mimic (S129D) α-
synuclein exhibited nearly normal phenotypes. Biochemical fractionation revealed that the level of membrane-bound α-
synuclein was significantly increased in S129A-α-synuclein Tg worms, whereas S129D- as well as A30P-α-synuclein displayed lower membrane binding properties. Furthermore, A30P/S129A double mutant α-
synuclein did not cause neuronal dysfunction and displayed low membrane binding property. In human
neuroblastoma SH-SY5Y cells, localization of S129A-α-synuclein to membranes was significantly increased. Finally, gene expression profiling of S129A-Tg worms revealed a dramatic up-regulation of Daf-16/FOXO pathway genes, which likely act against the dysfunction caused by S129A-α-synuclein. These results imply a role of Ser-129 phosphorylation of α-
synuclein in the attenuation of α-
synuclein-induced neuronal dysfunction and downstream stress response by lowering the membrane binding property.